Pfizer Inc. (NYSE: PFE) Q4 2020 earnings call dated Feb. 02, 2021
Corporate Participants:
Charles E. Triano — Senior Vice President, Investor Relations
Albert Bourla — Chairman and Chief Executive Officer
Mikael Dolsten — Chief Scientific Officer and President, Worldwide Research, Development and Medical
Angela Hwang — Group President, Pfizer Biopharmaceuticals Group
Frank D’Amelio — Chief Financial Officer and Executive Vice President, Global Supply
John Young — Group President, Chief Business Officer
Analysts:
David Risinger — Morgan Stanley — Analyst
Steve Scala — Cowen — Analyst
Gregg Gilbert — Truist Securities — Analyst
Louise Chen — Cantor Fitzgerald — Analyst
Umer Raffat — Evercore — Analyst
Geoffrey Porges — SVB Leerink — Analyst
Vamil Divan — Mizuho — Analyst
Tim Anderson — Wolfe Research — Analyst
Jason Zemansky — Bank of America — Analyst
Ronny Gal — Bernstein — Analyst
Navin Jacob — UBS — Analyst
Chris Schott — JPMorgan — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
Key metrics from Kroger’s (KR) Q3 2025 earnings results
The Kroger Co. (NYSE: KR) reported its third quarter 2025 earnings results today. Total company sales rose to $33.9 billion from $33.6 billion in the same period last year. Identical
Dollar General (DG) Q3 2025 Earnings: Key financials and quarterly highlights
Dollar General Corporation (NYSE: DG) reported its third quarter 2025 earnings results today. Net sales increased 4.6% year-over-year to $10.65 billion. Same-store sales increased 2.5%. Net income was $282.7 million, or
HRL Earnings: All you need to know about Hormel Foods’ Q4 2025 earnings results
Hormel Foods Corporation (NYSE: HRL) reported its fourth quarter 2025 earnings results today. Net sales increased 1.5% year-over-year to $3.18 billion. Organic sales were up 2%. Net loss attributable to Hormel
Listen On
